Outlook For Heart Failure Drugs Entresto And Corlanor Finally Looking Up

New US and European cardiology guidelines recommend Novartis' Entresto and Amgen's Corlanor, and coverage for both is coming soon with one major insurer.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America